BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1139 related articles for article (PubMed ID: 32708317)

  • 81. Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways.
    Liao C; Cheng T; Wang S; Zhang C; Jin L; Yang Y
    Bone; 2017 Aug; 101():10-20. PubMed ID: 28414140
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity.
    Li B; Lu D; Chen Y; Zhao M; Zuo L
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110777
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
    Sapir-Koren R; Livshits G
    Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 85. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.
    Yao Z; Lei W; Duan R; Li Y; Luo L; Boyce BF
    J Biol Chem; 2017 Jun; 292(24):10169-10179. PubMed ID: 28438834
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis.
    Kramer I; Halleux C; Keller H; Pegurri M; Gooi JH; Weber PB; Feng JQ; Bonewald LF; Kneissel M
    Mol Cell Biol; 2010 Jun; 30(12):3071-85. PubMed ID: 20404086
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Melatonin and bone status].
    Ostrowska Z; Wołkowska-Pokrywa K; Kos-Kudła B; Swietochowska E; Marek B; Kajdaniuk D
    Pol Merkur Lekarski; 2006 Oct; 21(124):389-93. PubMed ID: 17205785
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption.
    Tan SD; de Vries TJ; Kuijpers-Jagtman AM; Semeins CM; Everts V; Klein-Nulend J
    Bone; 2007 Nov; 41(5):745-51. PubMed ID: 17855178
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The osteoclast, bone remodelling and treatment of metabolic bone disease.
    Boyce BF; Rosenberg E; de Papp AE; Duong LT
    Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Apoptotic Osteocytes Induce RANKL Production in Bystanders via Purinergic Signaling and Activation of Pannexin Channels.
    McCutcheon S; Majeska RJ; Spray DC; Schaffler MB; Vazquez M
    J Bone Miner Res; 2020 May; 35(5):966-977. PubMed ID: 31910292
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
    Kassem A; Lindholm C; Lerner UH
    PLoS One; 2016; 11(6):e0156708. PubMed ID: 27311019
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Osteoclasts have multiple roles in bone in addition to bone resorption.
    Boyce BF; Yao Z; Xing L
    Crit Rev Eukaryot Gene Expr; 2009; 19(3):171-80. PubMed ID: 19883363
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Receptor activator of nuclear factor-κB ligand and sclerostin expression in osteocytes of alveolar bone in rats with ligature-induced periodontitis.
    Kim JH; Lee DE; Cha JH; Bak EJ; Yoo YJ
    J Periodontol; 2014 Nov; 85(11):e370-8. PubMed ID: 25070541
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin
    Ma J; Wang A; Zhang H; Liu B; Geng Y; Xu Y; Zuo G; Jia P
    Bone; 2022 Nov; 164():116511. PubMed ID: 35933095
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
    Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
    J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
    [TBL] [Abstract][Full Text] [Related]  

  • 99. FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions.
    Zhang C; Wei W; Chi M; Wan Y; Li X; Qi M; Zhou Y
    J Diabetes Res; 2019; 2019():6757428. PubMed ID: 31886284
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.